Enliven Therapeutics, Inc (ELVN) Misses Q4 EPS by 47c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.47).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners